Peptide PilotPeptide Pilot
Download on the App Store

Comparison

Sermorelin vs Tesamorelin

Sermorelin against tesamorelin — both GHRH analogs, very different half-lives and very different studied populations.

Download on the App StoreiPhone · Free to download
Field
Sermorelin
Tesamorelin
Category
GH Secretagogue
GH Secretagogue
Common alias
—
—
Example vial
5 mg + 2 mL BAC water
5 mg + 2 mL BAC water
Concentration
2.50 mg/mL
2.50 mg/mL
Example dose
0.2 mcg
1 mg
Doses per week
7× / week
7× / week
Doses per vial (rounded down)
25
5
Approx vial duration
3.6 weeks
0.7 weeks

Sermorelin and Tesamorelin both show up in the same conversations, but they aren't interchangeable. The table above lays the vial math side by side so you can see how concentration, doses-per-vial, and weekly cadence actually compare. The sections below walk through what each one is, how each is studied, and how each shows up in a tracked log — in plain English, no recommendations.

Tiebreakers

Where Sermorelin and Tesamorelin actually diverge

SermorelinTesamorelin
Cadence7/wk7/wk
Concentration on example2.50 mg/mL2.50 mg/mL
Math weeks per vial3.60.7
CategoryGH SecretagogueGH Secretagogue

Bolded values are the higher of the two on numeric rows. Same-value rows aren't a verdict — they're shared properties.

Sermorelin vs Tesamorelin: the actual decision

Both of these molecules are GHRH analogs, but they were studied in completely different populations and that shapes how the comparison reads. Sermorelin is the original GHRH(1-29) fragment, with most of its data coming from age-related GH-deficiency work and pediatric short-stature studies. Tesamorelin is a stabilized GHRH analog approved specifically for HIV-associated lipodystrophy and studied at length for visceral fat reduction. The mechanism is the same; the studied use cases are not.

Half-life is the structural difference between the two. Sermorelin's half-life is on the order of 10–20 minutes; tesamorelin's modified structure stretches it to roughly 30 minutes to an hour, with effective biological action longer than the raw plasma half-life suggests. Both molecules are typically administered daily in their respective protocols, but the dose magnitudes are different — tesamorelin protocols usually sit around 1–2 mg daily while sermorelin protocols are often in the 100–500 mcg range.

Mechanism, cadence, and what shows up in a log

In a log the two molecules look more different than the shared mechanism would suggest. Tesamorelin logs frequently include a waist-circumference field because the published evidence base is so heavily weighted toward visceral-fat measurements. Sermorelin logs tend to focus on sleep quality, morning energy, and recovery markers because that is how the off-label use case is usually framed. Both molecules log cleanly as a single daily event.

Reconstitution mechanics are identical, but the unit math on a 100-unit syringe is quite different because tesamorelin's per-dose milligrams are roughly 4–10x sermorelin's. A 5 mg tesamorelin vial reconstituted with 2 mL hits 2.5 mg/mL, which puts a 1 mg dose at 0.4 mL or 40 units; a 5 mg sermorelin vial at the same concentration puts a 200 mcg dose at 0.08 mL or 8 units. The mg-to-units calculator linked below handles either once vial concentration is set.

Sermorelin vs Tesamorelin: the numbers, side by side

Start with what actually goes into a syringe. The example Sermorelin vial on this site reconstitutes 5 mg in 2 mL of bacteriostatic water — about 2.50 mg per mL, which yields roughly 25 doses at the 200 mcg example and lasts about 3.6 weeks at 7 doses per week. The example Tesamorelin vial reconstitutes 5 mg in 2 mL (2.50 mg/mL), which yields about 5 doses at 1 mg and stretches roughly 0.7 weeks at 7 doses per week. Those numbers are the starting point most people forget to write down, and they decide everything downstream — refill timing, unit count on the syringe barrel, and whether a 30-mL bac-water bottle stretches across one vial or two.

Category context matters too. Both Sermorelin and Tesamorelin sit in the GH Secretagogue bucket, so the head-to-head questions readers bring here are usually about cadence, titration step size, and which of the two molecules logs more cleanly inside a longer protocol rather than a from-scratch category choice. Cadence helps frame the rest: Sermorelin is logged about 7× per week in the example schedule, Tesamorelin about 7×.

The single most-asked-about mistake on each page is worth surfacing here, because they rarely overlap. On the Sermorelin side: Mistaking its short half-life for a lack of activity and consequently attempting to use multi-day dosing intervals. On the Tesamorelin side: Assuming the per-dose volume and syringe draw will be as small as sermorelin's and failing to plan for a larger subcutaneous injection. Both are the kind of thing a tracked log catches early and an untracked routine catches late.

Top Sermorelin question
Why is Sermorelin composed of only the first 29 amino acids of GHRH?

Sermorelin is structured as the N-terminal fragment of native Growth Hormone-Releasing Hormone because extensive research identified this segment as the biologically active region. These 29 amino acids are sufficient for binding to and stimulating the GHRH receptor with the same efficacy as the full 44-amino-acid hormone. The remaining C-terminal portion of the natural peptide is not required for this primary function.

Top Tesamorelin question
Why is the Tesamorelin dose in milligrams (mg) when other GHRH analogs are often dosed in micrograms (mcg)?

Tesamorelin's milligram-level dosing is a function of its molecular structure and the extensive clinical research that established its use profile. As the full 44-amino-acid GHRH sequence, its molecular weight and receptor affinity necessitate a larger mass to achieve the desired level of pituitary stimulation. The protocols for its FDA-approved indication were developed around a 1 mg or 2 mg daily dose, reflecting its distinct pharmacology compared to smaller, truncated peptide fragments.

The calculator pages linked below let you swap your own vial size, diluent volume, and dose into the same math — these example numbers exist so the comparison renders with concrete figures instead of placeholders.

Frequently asked questions about Sermorelin vs Tesamorelin

Why is Sermorelin composed of only the first 29 amino acids of GHRH?
Sermorelin is structured as the N-terminal fragment of native Growth Hormone-Releasing Hormone because extensive research identified this segment as the biologically active region. These 29 amino acids are sufficient for binding to and stimulating the GHRH receptor with the same efficacy as the full 44-amino-acid hormone. The remaining C-terminal portion of the natural peptide is not required for this primary function.
What is meant by a 'pulse-preserving' stimulus in the context of Sermorelin?
This term describes how Sermorelin's rapid action and clearance imitate a natural GHRH signal from the brain. It causes a discrete, short-lived release of GH from the pituitary, after which the peptide is quickly eliminated from the system. This mechanism allows the body's own regulatory feedback loops and subsequent natural GH pulses to function without interference, in contrast to the sustained hormone levels produced by direct GH administration.
Why is Sermorelin's dosing schedule typically set for right before bed?
The human body's most significant natural surge of GH occurs during the early stages of deep sleep, shortly after nightfall. By scheduling a Sermorelin dose immediately before sleep, the peptide's peak action is timed to coincide with this powerful natural event. This strategy aims to amplify the body's own largest GH pulse instead of generating a separate pulse at a non-physiological time.
Why is the Tesamorelin dose in milligrams (mg) when other GHRH analogs are often dosed in micrograms (mcg)?
Tesamorelin's milligram-level dosing is a function of its molecular structure and the extensive clinical research that established its use profile. As the full 44-amino-acid GHRH sequence, its molecular weight and receptor affinity necessitate a larger mass to achieve the desired level of pituitary stimulation. The protocols for its FDA-approved indication were developed around a 1 mg or 2 mg daily dose, reflecting its distinct pharmacology compared to smaller, truncated peptide fragments.
What specifically is the purpose of the trans-3-hexenoyl group on Tesamorelin?
The trans-3-hexenoyl group is a fatty acid-based modification chemically bonded to the start of the peptide chain. Its sole purpose is to serve as a physical shield, sterically hindering the enzyme DPP-IV from accessing its cleavage site on the GHRH sequence. This protection from enzymatic degradation is what grants Tesamorelin a significantly longer half-life compared to native GHRH, which is its primary design advantage.
Using a 5 mg vial reconstituted with 2 mL of water, how many units would a 1 mg dose be?
When a 5 mg vial is reconstituted with 2 mL of bacteriostatic water, the solution's final concentration is 2.5 mg/mL. To obtain a 1 mg dose from this solution, you would need to draw 0.40 mL. On any standard U-100 insulin syringe, a volume of 0.40 mL is equivalent to exactly 40 units.

Related on Peptide Pilot

Log Sermorelin and Tesamorelin side by side in the app

Download on the App StoreiPhone · Free · No credit card
Download on theApp Store→